◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states ◇ Physician-supervised protocols◇ Third-party tested · COA on every lot◇ 99%+ verified purity◇ Cold-chain shipping in 48 hours◇ Licensed in 43 states
Home / Formulary / Selank
Back to formulary
Selank — LORIUM lyophilised vial LORIUM · 5 mg LYOPHILISED VIAL
Third-party tested · COA included with every lot
Cognitive ● In stockPrescription required

Selank

Anxiolytic peptide · SELANK

Selank is a premium synthetic heptapeptide derived from tuftsin, engineered to deliver profound anxiolytic and neuroprotective optimization. By modulating serotonergic and GABAergic pathways in the brain, this protocol effectively reduces anxiety and stabilizes mood while sharpening learning focus and systemic stress resilience.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. It is dispensed only pursuant to a valid prescription following evaluation by a licensed provider.

Researched effects

Effects observed in the cited literature. Individual results are not guaranteed. Statements have not been evaluated by the FDA.

BDNF Activation

Promotes a powerful increase in vital Brain-Derived Neurotrophic Factors.

Memory Consolidation

Actively optimizes pathways responsible for learning and retention.

Neuroplasticity Support

Accelerates the development of healthy neural pathways.

Anxiety Relief

Regulates neurotransmitters to calm the CNS without sedation.

Neuro Protection

Safeguards vital brain structures from oxidative stress.

Neurotransmitter Balance

Supports steady synthesis and release of dopamine and serotonin.

Stress Adaptation

Enhances cellular survival and performance during high-stress routines.

Specifications

ClassAnxiolytic peptide
CAS number80714-61-0
Molar mass751.9 g/mol
Available sizes5 mg, 10 mg
AdministrationPremium subcutaneous or intranasal protocol.
CategoryCognitive
View a sample certificate of analysis →

Clinical references

  1. Zozulya AA, Neznamov GG, Syunyakov TS, et al. Efficacy and mechanisms of action of the peptide anxiolytic Selank in generalized anxiety disorder. Bull Exp Biol Med. 2008;146(3):337-340.
  2. Medvedev VE, Tereshchenko ON, Israelyan AY, et al. Comparison of the anxiolytic effect and tolerability of Selank and medazepam. Zh Nevrol Psikhiatr Im S S Korsakova. 2015.
  3. Kolomin T, Shadrina M, Slominsky P, et al. A new generation of drugs: synthetic peptides based on natural regulatory peptides. Selank. Neurosci Behav Physiol. 2013.
Related

More in Cognitive

View all →